{
    "title": "Individual feed for http://feeds.benzinga.com/benzinga",
    "link": "http://feeds.benzinga.com/benzinga",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-29T11:02:13.634452",
    "items": [
        {
            "title": "Dow Falls Over 100 Points; US Pending Home Sales Rise In November",
            "link": "https://www.benzinga.com/markets/market-summary/25/12/49611367/dow-falls-over-100-points-us-pending-home-sales-rise-in-november",
            "description": "read more",
            "pubDate": "2025-12-29T15:19:02",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/12/29/Tallinn--Estonia---August-4th-2023---Scr.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "If You Invested $100 In Kinder Morgan Stock 5 Years Ago, You Would Have This Much Today",
            "link": "https://www.benzinga.com/insights/news/25/12/49611280/if-you-invested-100-in-kinder-morgan-stock-5-years-ago-you-would-have-this-much-today",
            "description": "read more",
            "pubDate": "2025-12-29T15:17:08",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "Ultragenyx-Mereo Bone Drug Trial Disappoints, Stocks Hit 52-Week Lows",
            "link": "https://www.benzinga.com/news/health-care/25/12/49611215/ultragenyx-mereo-bone-drug-trial-disappoints-stocks-hit-52-week-lows",
            "description": "Ultragenyx and Mereo BioPharma hit 52-week low after disappointing results from Phase 3 studies for Osteogenesis Imperfecta treatment. read more",
            "pubDate": "2025-12-29T15:15:16",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/12/29/Market--Down--Creative-Crash-Recession-C.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Sam Altman Says He's 'Envious of the Current Generation of 20-Year-Old Dropouts'",
            "link": "https://www.benzinga.com/personal-finance/financial-advisors/25/12/49610527/sam-altman-says-hes-envious-of-the-current-generation-of-20-year-old-dropouts",
            "description": "Sam Altman, CEO of OpenAI, expressed his admiration for the entrepreneurial success of Gen Z college dropouts. read more",
            "pubDate": "2025-12-29T15:01:22",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/12/29/Openai-Ceo-Sam-Altman-Attends-The-Artifi_0.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Analyzing Intel In Comparison To Competitors In Semiconductors &amp; Semiconductor Equipment Industry",
            "link": "https://www.benzinga.com/insights/news/25/12/49610537/analyzing-intel-in-comparison-to-competitors-in-semiconductors-amp-semiconductor-equipment-industry",
            "description": "read more",
            "pubDate": "2025-12-29T15:01:16",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_preview_1.jpg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        }
    ]
}